Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.64 |
| ▸ | LMNA | P02545 | 5/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.64 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.64 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 4/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | THPO | P40225 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | APEX1 | P27695 | 1/20 | 0.61 |
| ▸ | MTOR | P42345 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4258203 | 1.00 | KDM4E (0.64) | KDM4ELMNAHIF1AADRA2AADRA2C | |
| SCHEMBL14465577 | 1.00 | KDM4E (0.64) | KDM4ELMNAHIF1AADRA2AADRA2C | |
| SCHEMBL2252628 | 1.00 | KDM4E (0.64) | KDM4ELMNAHIF1AADRA2AADRA2C | |
| SCHEMBL5174891 | 1.00 | KDM4E (0.64) | KDM4ELMNAHIF1AADRA2AADRA2C | |
| SCHEMBL5076516 | 1.00 | KDM4E (0.64) | KDM4ELMNAHIF1AADRA2AADRA2C | |
| SCHEMBL723104 | 1.00 | KDM4E (0.64) | KDM4ELMNAHIF1AADRA2AADRA2C | |
| Hydrochloric Acid SCHEMBL5082770 | 0.98 | ALDH1A1 (0.65) | KDM4ELMNAHIF1AADRA2AADRA2C | |
| Hydrochloric Acid SCHEMBL1168030 | 0.98 | ALDH1A1 (0.65) | KDM4ELMNAHIF1AADRA2AADRA2C | |
| Hydrochloric Acid SCHEMBL5082784 | 0.98 | ALDH1A1 (0.65) | KDM4ELMNAHIF1AADRA2AADRA2C | |
| Hydrochloric Acid SCHEMBL7327569 | 0.98 | ALDH1A1 (0.65) | KDM4ELMNAHIF1AADRA2AADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110891562-B | Lithium salts of N-substituted glycine compounds and uses thereof | 心悦生医股份有限公司 | 2024-07-16 | — | — | CN | claimed |
| US-20090247781-A1 | SYNTHESIS OF PHENOXYACETIC ACID DERIVATIVES | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2009-10-01 | — | — | US | claimed |
| US-20070088174-A1 | Synthesis of phenoxyacetic acid derivatives | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-04-19 | — | — | US | claimed |
| US-4191777-A | Maleic acid halfamides having blood pressure raising activity | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1980-03-04 | — | — | US | claimed |
| US-20250134870-A1 | PATHWAY MODULATOR, PHARMACEUTICAL COMPOSITION HAVING SAME, USE THEREOF, AND THERAPEUTIC METHOD USING SAME | JIANGSU YAHONG MEDITECH CO., LTD. (CN) | 2025-05-01 | — | — | US | disclosed |
| CN-110891562-B | Lithium salts of N-substituted glycine compounds and uses thereof | 心悦生医股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| US-11906512-B2 | Integrated device for analyte testing, confirmation, and donor identity verification | Zeus Diagnostics, LLC (US) | 2024-02-20 | — | — | US | disclosed |
| CN-111479806-B | D-amino acid oxidase inhibitors and therapeutic uses thereof | 心悦生医股份有限公司 | 2024-01-30 | — | — | CN | disclosed |
| EP-4285898-A1 | PATHWAY MODULATOR, PHARMACEUTICAL COMPOSITION HAVING SAME, USE THEREOF, AND THERAPEUTIC METHOD USING SAME | Jiangsu Yahong Meditech Co., Ltd. (CN) | 2023-12-06 | — | — | EP | disclosed |
| CN-116490177-A | Pathway modulator, pharmaceutical composition containing the same, use thereof, and therapeutic method using the same | 江苏亚虹医药科技股份有限公司 | 2023-07-25 | — | — | CN | disclosed |
| EP-3490554-B1 | USES OF DOPAMINE BETA-HYDROXYLASE (DBH) INHIBITORS FOR THE TREATMENT OF CANCER | JIANGSU YAHONG MEDITECH CO LTD (CN) | 2023-07-05 | — | — | EP | disclosed |
| US-11571390-B2 | Abuse deterrent compositions and methods of use | Othemo Life Sciences, Inc. (US) | 2023-02-07 | — | — | US | disclosed |
| EP-0586585-A1 | 1,2-DIHYDROPYRIDO(3,4-B)PYRAZINES AS FUNGICIDES | SOUTHERN RESEARCH INSTITUTE (US) | 1994-03-16 | — | — | EP | disclosed |
| EP-0405344-B1 | 2-AMINO-1,2,3,4,-TETRAHYDRONAPHTHALENE DERIVATIVES WITH CARDIOVASCULAR ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CHIESI FARMACEUTICI S.p.A. (IT) | 1993-09-01 | — | — | EP | disclosed |
| WO-1992020680-A1 | 1,2-DIHYDROPYRIDO(3,4-B)PYRAZINES AS FUNGICIDES | SOUTHERN RESEARCH INSTITUTE (US) | 1992-11-26 | — | — | WO | disclosed |
| US-5096929-A | Inotropic agents; vasodilation | CHIESI FARMACEUTICI S.P.A. (IT) | 1992-03-17 | — | — | US | disclosed |
| US-5095017-A | 1,2-dihydropyrido(3,4,-b)pyrazines as fungicides | SOUTHERN RESEARCH INSTITUTE (US) | 1992-03-10 | — | — | US | disclosed |
| EP-0405344-A2 | 2-Amino-1,2,3,4,-tetrahydronaphthalene derivatives with cardiovascular activity, process for their preparation and pharmaceutical compositions containing them | CHIESI FARMACEUTICI S.p.A. (IT) | 1991-01-02 | — | — | EP | disclosed |
| US-4226803-A | Process for production of optically active bases | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1980-10-07 | — | — | US | disclosed |
| US-4191777-A | Maleic acid halfamides having blood pressure raising activity | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1980-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070088174-A1 | Synthesis of phenoxyacetic acid derivatives | DDC, PAH, HPD | KDM4E 422/4885LMNA 2880/4885HIF1A 861/4885 |
| US-20090247781-A1 | SYNTHESIS OF PHENOXYACETIC ACID DERIVATIVES | DDC, PAH, HPD | KDM4E 414/4885LMNA 3124/4885HIF1A 818/4885 |
| US-20250134870-A1 | PATHWAY MODULATOR, PHARMACEUTICAL COMPOSITION HAVING SAME, USE THEREOF, AND THERAPEUTIC METHOD USING SAME | DBH, COMT, ADRB1 | KDM4E 2506/4885LMNA 4831/4885HIF1A 1990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.